Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WP-1303 plus timolol vs placebo plus timolol in POAG or ocular hypertension
jRCT2080224839Phase 3Terminated
- Sponsor
- Wakamoto Pharmaceutical
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in open-angle glaucoma (OAG) and ocular hypertension comparing WP-1303 + timolol with Placebo + timolol (2 arms). Started Aug 2019; status: terminated.
02
Drugs
ripasudil + brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on jRCT2080224839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224839.